Although the data on the outcomes of liver transplant recipients with COVID-19 are inconsistent, there is a definite trend towards higher mortality risks in transplant recipients. 4 , 5 Liver transplant recipients or other immunocompromised patients were not included in the registration trials of mRNA vaccine studies for SARS-CoV-2.
← all excerpts
Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases.
1
—
—